Drug Trial Radar · NCT07160634
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Oct 22, 2025
Primary completion
Jan 2029
Study completion Jan 2034
Sponsor
- Lead sponsor
- Solid Biosciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 7 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, double-blind, placebo-controlled study with the primary objective of evaluating the efficacy of a single IV infusion of SGT-003 in pediatric ambulant male participants with DMD. The secondary objectives include the evaluation of additional efficacy and safety outcomes. The study will be divided into 2 parts. Participants will be randomized 1:1 to either SGT-003 in Part 1 followed by placebo in Part 2 or to placebo in Part 1 followed by SGT-003 in Part 2. Participants will continue to be monitored in long term follow up (LTFU) for at least 5 years from their SGT-003 dosing date.
Conditions
- Duchenne Muscular Dystrophy
Interventions
SGT-003Drug
Adeno-associated virus (AAV)-based gene therapy that delivers a codon-optimized and CpG island-minimized human 5-repeat microdystrophin (h-μD5)
PlaceboDrug
IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Time to Rise (TTR) from Supine Velocity (rise/s) at Day 540Time frame: Baseline, Day 540
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas · Not yet recruiting
Neurology Rare Disease Center
Flower Mound, Texas · Not yet recruiting
Children's Hospital of the King's Daughters
Norfolk, Virginia · Not yet recruiting
The Children's Hospital of Westmead
Sydney, New South Wales, Australia · Recruiting
Alberta Children's Hospital
Calgary, Alberta, Canada · Recruiting
BC Children's Hospital
Vancouver, British Columbia, Canada · Recruiting
The Hospital for Sick Children (SickKids)
Toronto, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.